
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
NGM BIOPHARMAC. 0IK US62921N1054 BAW/UFN
© 2024 Xetra Newsboard
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
09:10 | NGM Biopharmaceuticals, Inc.: NGM Bio Announces First Participant Dosed in EMERALD Phase 2 Clinical Study of NGM120 for the Treatment of Hyperemesis Gravidarum (HG) in Pregnant Patients | HG is a rare, debilitating condition of pregnancy, characterized by intractable nausea and uncontrollable vomiting and frequent, serious complicationsAn increase in the hormone GDF15 is believed to... ► Artikel lesen | |
05.04.24 | NGM Biopharmaceuticals, Inc.: NGM Bio Announces Closing of Tender Offer | SAN FRANCISCO, April 05, 2024 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. ("NGM Bio") (Nasdaq: NGM), a biotechnology company focused on discovering and developing transformative therapeutics... ► Artikel lesen | |
05.04.24 | XFRA 0IK: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILNGM BIOPHARMAC.... ► Artikel lesen |